The elevation of tumor immune checkpoint ligand PD-L1 after bariatric surgery may be one mechanism that underlies why surgical weight loss was less effective in reducing obesity-worsened tumor growth compared to weight loss alone. Here, CD274 is linked to obesity disorder.